Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

The Virtual NP vs Vea Health

The Virtual NP
Graded #316

Higher grade

vs+5.799999999999997
Vea Health
Graded #451

Lower grade

The verdict

The Virtual NP takes it — 60.8/100 to 55/100.

The Virtual NP grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The Virtual NP is a nurse-practitioner-led telehealth weight loss clinic prescribing FDA-approved branded GLP-1 medications, Zepbound (tirzepatide) and Wegovy (semaglutide), from Eli Lilly and Novo Nordisk.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationThe Virtual NP +2
53
51
Clinical oversightThe Virtual NP +28
94
66
Labs & monitoringThe Virtual NP +2
54
52
FulfillmentVea Health +4
64
68
Contract termsEven
55
55
The Virtual NP · left barVea Health · right bar

The numbers

MetricThe Virtual NPVea Health
WeighScore60.8/10055/100
GradeCC
Scorecard rank#316#451
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
Coverage7 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
The Virtual NP

Graded #316 · C

Strengths

  • FDA-approved branded Zepbound and Wegovy only, no compounded
  • Transparent fees: 99 visit or 75 per month membership
  • HSA/FSA accepted and prior authorization assistance offered
  • NP-led with same or next-day booking and home shipping

Where it loses points

  • Branded only, so medication cost is high and billed separately
  • Limited to seven states
  • No compounded lower-cost GLP-1 alternative
  • Single-provider practice may limit scale and hours
Vea Health

Graded #451 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard